DCGI flags regulatory risks as Pharma industry races to embrace AI at IIMA healthcare summit

Source: BusinessLine· Avinash Nair· August 22, 2026
DCGI flags regulatory risks as Pharma industry races to embrace AI at IIMA healthcare summit

The DGCI said regulators approve a product based on defined characteristics of quality, safety and performance and expect those characteristics to remain consistent through the product’s lifecycle

This story was reported by BusinessLine. Read the full original article:
Read on BusinessLine

More in Ethics & Safety

View all